LETTER TO EDITOR |
[Download PDF] |
|
| Year : 2010 | Volume
: 42
| Issue : 2 | Page : 116- |
Authors' reply
Harminder Singh, N Dulhani, Kumar Bithika Nel
Government Medical College, Jagdalpur, Bastar, Chhattisgarh, India
Correspondence Address:
Harminder Singh
Government Medical College, Jagdalpur, Bastar - 494 001, Chhattisgarh
India
How to cite this article:
Singh H, Dulhani N, Nel KB. Authors' reply.Indian J Pharmacol 2010;42:116-116
|
How to cite this URL:
Singh H, Dulhani N, Nel KB. Authors' reply. Indian J Pharmacol [serial online] 2010 [cited 2023 Jun 10 ];42:116-116
Available from: https://www.ijp-online.com/text.asp?2010/42/2/116/64492 |
Full Text
Sir,
This is with reference to the comments on our article. [1] The necessary clarifications are given as follows.
Hepatitis has been shown as an adverse drug reaction (ADR) to HAART, but some other studies do not report it commonly. We reported hepatotoxicity which includes hepatitis also. [2],[3] Out of 79 patients, 68 had at least one ADR (reported) and 11 patients had no ADR at all. A total of 120 ADRs were reported since some patients had multiple ADRs. Out of 137 patients, 15 died due to terminal AIDS, 9 were lost to follow up due to change in address, etc, 18 were excluded from the study, and 16 were non-compliant (stopped therapy) and non-adherent to the follow-up protocol. Most severe ADRs were anemia and hepatotoxicity. Severity grading was classified according to the Hartwig and Siegel scale. [4] The correlation of ADRs with age, sex and CD4 count was done. Further analysis of difference in average age and CD4 count among males and females, though helpful, should not undermine the scope and information provided by our study.
References
| 1 | Singh H, Dulhani N, Tiwari P, Singh P, Sinha T. A prospective, observational cohort study to elicit adverse effects of antiretroviral agents in a remote resource-restricted tribal population of Chhattisgarh. Indian J Pharmacol 2009;41:224-6. |
| 2 | Balakrishnan K. Safety, tolerability and effectiveness of locally produced generic antiretroviral drugs in persons with HIV disease in Southern India. Int Cong Drug Ther HIV 2002;6:298. |
| 3 | Malangu NG. Self-Reported Adverse Effects as Barriers to Adherence to Antiretroviral Therapy in HIV-Infected Patients in Pretoria. SA FAM pract 2008;50:49. |
| 4 | Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49:2229-32. |
|
